.jpg)
.jpg)
Methylphenidate sold as MDMA
Risk assessment
These micropellets sold as MDMA do not contain MDMA but methylphenidate.
Methylphenidate is mainly prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Taking methylphenidate increases the concentration of the nerve messengers dopamine, noradrenaline and serotonin in the brain, which leads to a stimulating, energising and drive-enhancing effect.
Since the spectrum of action of methylphenidate is relatively different from MDMA and the dosage is somewhat lower, there is a risk of refilling and overdosing. Higher doses of methylphenidate can lead to seizures, cardiac arrhythmias as well as headaches and confusion. In addition, very high doses can also trigger hallucinations.
Alert level
Information
Caution
Alerts
Information
Caution
Alerts
Information
Caution
Alerts
Safer Use
Analysis
Have your substances tested in a Drug Checking
Testing
If you do not have the possibility to have substances analysed, always test a small amount to avoid overdoses.
Wait and see
Wait 2 hours after oral intake, as there are always powders / crystals in circulation with unexpected active ingredients, which can have a later onset of action.
Utensils
Always use your own sniffing utensils when applying powders nasally (sniffing) to avoid infecting yourself or others with diseases.
Disclaimer
If you are in possession of a substance that does not appear on this page, this in no way means that it contains the expected ingredient or that it should be safe. The warnings we publish only refer to the substances listed in our Drug Checking offers, these substances pose a high risk of consumption and should not be consumed. A substance may have the same visual appearance (shape, size, colour, etc.) and yet have different ingredients or a different composition. There is no drug use without risk! Only a complete renunciation of drugs is risk-free! If you still decide to use drugs, you should at least follow the safer use rules.
